S. Hesse, G. Kirsch / Tetrahedron Letters 44 (2003) 97–99
99
than 5-exocyclization. So, cyclization of 13 was per-
formed in the presence of 20 mol% of silver nitrate in
dry acetone during 24 h at room temperature, in the
dark and under an argon atmosphere; this process
allowed the synthesis of 14 with 55% yield (cf. Scheme
3).
7.48 (s, 1H2), 7.84 (d, 2H, J=7.9 Hz); lC (CDCl3) 18.90
(CH2), 21.32 (CH2), 106.22 (CH, C9), 110.87 (CH, C1),
117.87 (C9b), 128.79 (CH), 128.93 (CH), 130.62 (CH),
133.13 (C), 134.01 (C), 141.31 (C), 143.32 (CH, C2),
145.22 (C), 157.51 (C), 167.76 (CO2)
In conclusion, we described here new synthetic access to
furocoumarin derivatives via cross-coupling reaction of
triflate ester.
References
1. Knobler, R. M.; Honigsmann, H.; Edelson, R. L. In
Psoralen DNA Photobiology; Gasparro, F. P., Ed.; CRC
Press: Boca Raton, FL, 1988; Vol. II, p. 117.
2. Saffran, W. A. In Psoralen DNA Photobiology; Gasparro,
F. P., Ed.; CRC Press: Boca Raton, FL, 1988; Vol. II, p.
73.
3. Dall’Acqua, F.; Vedaldi, D.; Caffieri, S.; Guiotto, A.;
Bordin, F.; Rodighiero, P. Natl. Cancer Inst. Monogr.
1984, 66, 55.
3. Data for compounds 10, 11 and 14
1H and 13C NMR spectra were recorded on a AC
Bruker 250 MHz spectrometer in CDCl3.
3.1. 3,4-Dioxacyclopenta[c]phenanthren-6-one 10
4. Carlassare, F.; Baccichetti, F.; Guiotto, A.; Rodighiero,
P.; Gia, O.; Capozzi, A.; Pastorine, G.; Bordin, F. J.
Photochem. Photobiol. B: Biol. 1990, 5, 25.
5. Blais, J.; Averbeck, D.; Moron, J.; Bisagni, E.; Vigny, P.
Photochem. Photobiol. 1987, 45, 463.
Colorless solid; mp: 156°C; lH (CDCl3) 7.44–7.45 (m,
2H), 7.53–7.54 (m, H1+H), 7.72 (d, H4, J=8.6 Hz), 7.92
(d, H2, J=2.3 Hz), 8.36 (d, H, J=8.0 Hz), 8.42 (d, H5,
J=8.7 Hz); lC (CDCl3) 107.22 (CH, C1), 113.15 (CH,
C8), 117.14 (C), 117.77 (CH, C4), 118.86 (C), 121.85
(C), 124.41 (CH), 125.12 (CH), 127.04 (CH), 130.01
(C), 130.22 (CH), 146.97 (CH, C2), 151.41 (C7a), 158.76
(C3a), 161.34 (CO2, C6).
6. Adam, W.; Qian, X.; Saha-Mo¨ller, C. R. J. Org. Chem.
1993, 58, 3769.
7. Jakobs, A. E.; Christiaens, L. J. Org. Chem. 1996, 61,
4842.
8. Fossa, P.; Mosti, L.; Menozzi, G.; Marzano, C.; Bacci-
chetti, F.; Bordin, F. Bioorg. Med. Chem. 2002, 10, 743.
9. Hesse, S.; Kirsch, G. Tetrahedron Lett. 2002, 43, 1213.
10. Matsumoto, M.; Watanabe, N. Heterocycles 1984, 22
(10), 2313.
3.2. 4,5-Dihydro-3,4-dioxacyclopenta[c]phenanthren-6-
one 11
Yellow oil; lH (CDCl3) 2.97–2.10 (m, 2H), 3.05–3.08
(m, 2H), 7.00 (d, 1H1, J=2.1 Hz), 7.33–7.40 (m, 2H),
7.50–7.56 (m, 2H), 8.04 (d, 1H11, J=7.9 Hz).
11. Feist, F. Ber. 1902, 35, 1539.
12. Diamanti, J.; Cayen, C.; Bingham, R.; Krapcho, A. P.
Org. Synth. Coll. Vol. 5, 47, 20.
13. Oh-e, T.; Miyaura, N.; Suzuki, A. J. Org. Chem. 1993,
58, 2201.
3.3. 8-Phenyl-4,5-dihydrofuro[3,2-f ]isochromen-6-one 14
14. Bellina, F.; Ciucci, D.; Vergamini, P.; Rossi, R. Tetra-
hedron 2000, 56, 2533.
Yellow oil; lH (CDCl3) 2.84–2.91 (m, 2H), 2.97–3.09
(m, 2H), 6.21 (s, 1H1), 6.70 (s, 1H9), 7.30–7.44 (m, 3H),